
Did Plozasiran Really Reduce Pancreatitis by 100%? What the SHASTA-3 and SHASTA-4 Data Actually Show
Plozasiran produced striking Phase 3 results in severe hypertriglyceridemia, including a reported 100% reduction in pancreatitis events in the highest-risk subgroup. The number is real,








